Skip to main content
Viswam Nair, MD, Pulmonology, Seattle, WA

ViswamSivaNairMDMS

Pulmonology Seattle, WA

Critical Care Medicine, Pleural Disease, Thoracic Oncology

Section Chief, Pulmonary/Critical Care Medicine at Moffitt Cancer Center & Research Institute; Assistant Professor, University of South Florida. Morsani College of Medicine

Dr. Nair is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Nair's full profile

Already have an account?

  • Office

    825 Eastlake Ave E
    Seattle, WA 98109
    Phone+1 206-520-5000

Education & Training

  • Stanford University
    Stanford UniversityMS, Clinical Epidemiology, 2011 - 2012
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2007 - 2010
  • Santa Clara Valley Medical Center
    Santa Clara Valley Medical CenterResidency, Internal Medicine, 2004 - 2007
  • Ohio State University College of Medicine
    Ohio State University College of MedicineClass of 2004
  • University of Pennsylvania
    University of PennsylvaniaBA, Chemistry , Cum Laude, 1994 - 1998

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2006 - 2026
  • WA State Medical License
    WA State Medical License 2019 - 2026
  • FL State Medical License
    FL State Medical License 2017 - 2020
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Critical Care Medicine
  • American Board of Internal Medicine Pulmonary Disease

Publications & Presentations

PubMed

Press Mentions

  • Transformative $78M Gift to Establish New Precision Oncology Institute
    Transformative $78M Gift to Establish New Precision Oncology InstituteSeptember 8th, 2022